Today: 1 March 2026
Browse Category

NYSE:FMC 30 October 2025 - 10 February 2026

FMC stock price jumps nearly 7% as traders weigh strategic review and fresh Citi target cut

FMC stock price jumps nearly 7% as traders weigh strategic review and fresh Citi target cut

FMC shares jumped 7% to $16.46 Tuesday morning, extending gains after the company launched a strategic review that could include a sale and warned of weaker 2026 results. Citigroup cut its price target to $14 but kept a Neutral rating. Moody’s downgraded FMC’s debt to junk, citing increased event risk. The company’s annual shareholder meeting is set for April 28.
10 February 2026
FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

FMC Corp shares plunged 42% to $16, their lowest since 2016, after the company posted a $569 million quarterly loss and slashed its dividend by 80%. Revenue fell 49% year-over-year, hit by a $510 million write-down tied to its India business. The company cut its 2024 outlook and announced President Ronaldo Pereira will step down December 15. Analysts downgraded the stock and trimmed price targets.
30 October 2025
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 30.10.2025

US stocks fell Oct. 30, with the S&P 500 down 0.99% and Nasdaq off 1.57%. Oracle shares dropped 6.8% to $256.28 despite analysts raising price targets and maintaining buy ratings. Liberty Latin America slid about 6% in a month, closing near $7.77, well below its $10.63 fair value estimate. Intensity Therapeutics surged nearly 400%, while CERO plunged almost 95%.
Go toTop